Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 7 (HNRNPA1P7)

Target
HNRNPA1P7
Molecular classification
Other (pseudogene)
01

Overview

**Heterogeneous nuclear ribonucleoprotein A1 pseudogene 7 (HNRNPA1P7)** is classified as a pseudogene, meaning it is a DNA sequence similar to the protein-coding HNRNPA1 gene but is considered non-functional and does not encode a functional protein[1][10]. Pseudogenes arise from duplication or retrotransposition events and usually accumulate mutations that prevent protein production[7][10]. HNRNPA1P7 should not be confused with the parental HNRNPA1 gene, which encodes a highly abundant and functionally important RNA-binding protein involved in RNA splicing, telomere maintenance, and other crucial cellular processes[2][3][8][11]. By definition and current annotations, HNRNPA1P7 itself is NOT a therapeutic target, enzyme, transporter, or receptor, and there are no known drugs, mechanisms of action, or biomarker roles directly attributed to it[10]. Some pseudogenes have been implicated in gene regulation at the RNA level or associated with disease states via regulatory or competitive endogenous RNA (ceRNA) action, but there is no specific evidence supporting such a function for HNRNPA1P7 at present[7]. **Summary**: - HNRNPA1P7 is a non-functional pseudogene related to the HNRNPA1 family[10][1]. - It is NOT a drug target and encodes no known protein product[10]. - Alternative symbols/aliases: HNRPA1L3[1][10]. - No current evidence links HNRNPA1P7 directly to human disease or therapeutic targeting. - Should be clearly distinguished from the functional HNRNPA1 gene.

Other names
HNRPA1L3
02

Biological functions

no known protein-coding function; however, may have sequence-related regulatory roles consistent with other pseudogenes
03

Disease associations

pseudogene expression patterns have been linked to various cancers and diseases, but there is no direct evidence for HNRNPA1P7 itself

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 7 (HNRNPA1P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 7 (HNRNPA1P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call